Cranberry Supplement for UTIs

The UTI Struggle is Real — We Hear You

If you’ve ever had a UTI, you know how frustrating, painful, and disruptive it can be.

ellura^® is a scientifically backed, clinically proven supplement that helps to stop bacteria from sticking to the urinary tract and/or bladder^(1,3,5), reducing recurrent UTIs ^(6,7). Each capsule delivers 36mg of soluble bioactive PACs from 100% pure cranberry juice concentrate for maximum potency^(3,8).

BUY NOW

Say Goodbye to Recurrent UTIs

UTIs aren’t just painful, they disrupt your daily life and can lead to repeated antibiotic use, and an increasing risk of bacterial resistance^(4,6,7). ellura stops bacteria before infection starts, all in one powerful daily capsule.

LEARN MORE

Take Control of Your Urinary Tract Health

Our clinically proven, medical-grade solution helps reduce recurrent UTIs⁽⁷⁾

Starts working within a few hours to help protect your bladder

Trusted by thousands of women and healthcare providers

Safe for long-term use - no antibiotic resistance and no side effects⁽⁷⁾

TRY ELLURA

How is ellura Different?

ellura’s difference lies in its 36 mg of soluble, bioavailable PACs⁽²⁾— a clinically proven formula with superior absorption and the highest concentration of active PACs^(1,2,3), the key component responsible for preventing UTI-causing bacteria like E. coli from sticking to the urinary tract.
Many products claim to have PACs, but if sourced from insoluble cranberry pomace (seeds, stems, skin, pulp), they remain trapped in fiber and cannot be absorbed by the body^(2,15).
Our clinical research shows that only supplements with the highest levels of soluble PACs, like ellura, deliver powerful urinary tract defense ⁽²⁾.

BUY ELLURA

Take Control of Your Urinary Tract Health with ellura

ellura contains 36mg of soluble bioactive Proanthocyanidins (PACs) from 100% pure cranberry fruit juice concentrate (Vaccinium macrocarpon) — the key compound that helps prevent bacteria from sticking to the urinary tract and bladder, reducing the risk of recurrent UTIs ^(1,2,7).

BUY NOW

How ellura Works

Step 1. Bacteria Enter and Attach

E. coli migrates to the urinary tract, leading to infections.

Step 2. ellura Blocks Adhesion

The 36mg PACs in ellura prevent bacterial attachment to the bladder wall.⁽³⁾.

Step 3. Bacteria Are Flushed Out

Without attachment, bacteria are naturally eliminated through urine.

BUY NOW

Earn Rewards & Share the Benefits

We love rewarding our loyal customers! With My ellura Rewards & Referral Program, you can earn points on every purchase, redeem discounts, and share the benefits of ellura with your friends and family.

Already a member? Sign in to check your points and redeem rewards.

References

Howell, A. B., Vorsa, N., Der Marderosian, A., & Foo, L. Y. (1998). Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. The New England Journal of Medicine, 339(15), 1085–1086. https://doi.org/10.1056/NEJM199810083391516
Howell, A. B., Dreyfus, J. F., & Chughtai, B. (2022). Differences in urinary bacterial anti-adhesion activity after intake of cranberry dietary supplements with soluble versus insoluble proanthocyanidins. Journal of Dietary Supplements, 19(5), 621–639.
Howell, A. B., et al. (2010). Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: A multicentric randomized double blind study. BMC Infectious Diseases, 10, 94.
Anger, J. T., Bixler, B. R., Holmes, R. S., Lee, U. J., Santiago-Lastra, Y., & Selph, S. S. (2022). Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU Guideline. The Journal of Urology.
Bosley, S., Krueger, C. G., Birmingham, A., Howell, A. B., & Reed, J. D. (2024). Improved in vitro hemagglutination assays utilizing P-type and type 1 uropathogenic Escherichia coli to evaluate bacterial anti-adhesion activity of cranberry products. Journal of Dietary Supplements, 21(3), 327–343.
Storme, O., Tirán Saucedo, J., Garcia-Mora, A., Dehesa-Dávila, M., & Naber, K. G. (2019). Risk factors and predisposing conditions for urinary tract infection. Therapeutic Advances in Urology, 11, 1756287218814382.
Uberos, J., et al. (2012). Cranberry syrup vs trimethoprim in the prophylaxis of recurrent urinary tract infections among children: A controlled trial. Open Access Journal of Clinical Trials, 4, 31–38.
Lavigne, J. P., Bourg, G., Combescure, C., et al. (2008). In vitro and in vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clinical Microbiology and Infection, 14(4), 350–355.
Botto, H., & Neuzillet, Y. (2010). Effectiveness of a cranberry (Vaccinium macrocarpon) preparation in reducing asymptomatic bacteriuria in patients with an ileal enterocystoplasty. Scandinavian Journal of Urology and Nephrology, 44(3), 165–168.
Juthani-Mehta, M., et al. (2012). Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. Journal of the American Geriatrics Society, 60(6).
Thomas, D., et al. (2017). Does cranberry have a role in catheter-associated urinary tract infections? Canadian Urological Association Journal, 11(11), E421–E424.
Lavigne, J. P., Bourg, G., Botto, H., & Sotto, A. (2007). Cranberry (Vaccinium macrocarpon) and urinary tract infections: Study model and review of literature. Pathologie Biologie, 2007.07.005.

Are You a Healthcare Provider?

Discover how ellura can support your patients’ health.

LEARN MORE

Main menu